Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis

Respiratory Research

Takeshi Fukuda¹  Akihiro Takemasa¹  Kazuyuki Chibana¹  Ryo Arai¹  Mitsumi Hata-Suzuki¹  Yoshiki Ishii¹  Yumeko Hayashi¹ 

[1] Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Kitakobayashi 880, Mibu, Tochigi, 321-0293, Japan

关键词: CD141;    CD1a;    Myeloid DC (mDC);    Sarcoidosis;    Peripheral blood;    Dendritic cells;   

Others  :  794968
DOI  :  10.1186/1465-9921-14-29

 received in 2012-09-07, accepted in 2013-02-28,  发布年份 2013

【 摘 要 】

Background

Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in the initiation and modulation of immune responses. Human circulating blood DCs are divided into two major subsets: myeloid DCs (mDCs); and plasmacytoid DCs (pDCs). Furthermore, mDCs are subdivided into two subsets: Th1-promoting mDCs (mDC1s); and Th2-promoting mDCs (mDC2s). Although CD1a, CD1c, and CD141 are generally used for classifying mDC subsets, their adequacy as a specific marker remains unclear. We performed this study to compare circulating mDC, pDC, mDC1, and mDC2 subsets between Th1- and Th2-mediated diseases using CD1a and CD141, and to analyze the adequacy of CD1a and CD141 as a marker for mDC1s and mDC2s, respectively.

Methods

Thirty patients with sarcoidosis, 23 patients with atopic diseases, such as atopic bronchial asthma, and 23 healthy subjects as controls were enrolled in this study. Peripheral blood DC subsets were analyzed with flow cytometry according to expressions of CD11c, CD123, CD1a, and CD141. For functional analysis, we measured interleukin (IL) 12p40 levels produced by the sorted mDC subsets.

Results

The sarcoidosis group showed decreased total DC (P < 0.05) and mDC counts (P < 0.05) compared to controls. The atopy group showed decreased CD1a⁺mDC count (P < 0.05), and increased CD1a^-mDC count (P < 0.05) compared to controls. CD141⁺mDC count in the atopy group was higher than controls (P < 0.05). Sorted CD1a⁺mDCs produced higher levels of IL-12p40 than CD1a^-mDCs (P = 0.025) and CD141⁺mDCs (P = 0.018).

Conclusions

We conclude that decreased count of CD1a⁺mDC and increased count of CD141⁺mDC may reflect the Th2-skewed immunity in atopic diseases. The results of IL-12 levels produced by the sorted mDC subsets suggested the adequacy of CD1a and CD141 as a marker for mDC1 and mDC2, respectively, in vivo.

【 授权许可】

   
2013 Hayashi et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
• [2]Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
• [3]Sato K, Fujita S: Dendritic cells-nature and classification. Allergol Int 2007, 56:183-191.
• [4]Hart DN: Dendritic cells: unique leukocyte population, which control the primary immune response. Blood 1997, 90:3254-3287.
• [5]Ito T, Liu YJ, Kadowaki N: Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 2005, 81:188-196.
• [6]Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal MR, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
• [7]Moser M, Murphy KM: Dendritic cell regulation of TH1-TH2 development. Nature Immunol 2000, 3:199-205.
• [8]Ebner S, Hofer S, Nguyen VA, Fürhapter C, Herold M, Fritsch P, Heufler C, Romani N: A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 2002, 168:6199-6207.
• [9]Hata M, Takahara S, Tsuzaki H, Ishii Y, Nakata K, Akagawa KS, Satoh K: Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2). Immunol Lett 2009, 126:29-36.
• [10]Chang CC, Wright A, Punnonen J: Monocyte-derived CD1a+ and CD1a- DC subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2000, 165:3584-3591.
• [11]Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCA-3 and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000, 165:6037-6046.
• [12]Yerkovich ST, Roponen M, Smith ME, McKenna K, Bosco A, Subrata LS, Mamessier E, Wikström ME, Le Souef P, Sly PD, Holt PG, Upham JW: Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated TH2-skewed immune responses. J Allergy Clin Immunol 2009, 123:209-216.
• [13]Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJ, Hart DN, Radford KJ: Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010, 207:1247-1260.
• [14]Bratke K, Lommatzsch M, Julius P, Kuepper M, Kleine HD, Luttmann W, Christian VJ: Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 2007, 62(2):168-175.
• [15]JASOG criteria, report of research project ‘diffuse lung Diseases’ supported by ministry of public welfare. 1989, 160-162. in Japanese
• [16]Wurm K, Reindell H, Heilmyer L: Der Lun fenboek in Rontgebild. Stuttgart: George Thieme; 1958.
• [17]ATS/WASOG: Statement of sarcoidosis. Sarcoid Vasc Diffuse Lung Dis 1999, 16:147-173.
• [18]Matsuda H, Suda T, Hashizume H, Yokomura K, Asada K, Suzuki K, Chida K, Nakamura H: Alternation of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 2002, 166:1050-1054.
• [19]Perrot I, Blanchard D, Freqymond N, Issac S, Guilbert B, Pacheco Y, Lebecque S: Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J Immunol 2007, 178(5):2763-2769.
• [20]Almeida M, Cordero M, Almeida J, Orfao A: Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 2005, 19(3):261-271.
• [21]Autissier P, Soulas C, Burdo TH: Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A 010, 77:410-419.
• [22]Pinkston P, Bitterman P, Crystal R: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983, 308:793-800.
• [23]Robinson B, Mclemore T, Crystal R: Gamma interferon is spontaneously released by alveolar macrophage and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985, 75:1488-1495.
• [24]Prior C, Knight R, Herold M, Ott G, Spiteri M: Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 1996, 9:47-53.
• [25]Bümer I, Zissel G, Schlaak M, Müller-Quernheim J: Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997, 16:171-177.
• [26]Hoshino T, Itoh K, Gouhara R, Yamada A, Tanaka Y, Ichikawa Y, Azuma M, Mochizuki M, Oizumi K: Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients. Clin Exp Immunol 1995, 102:399-405.
• [27]Garlepp M, Rose A, Dench J, Robinson B: Clonal analysis of lung and blood T cells in patients with sarcoidosis. Thorax 1994, 49:577-585.
• [28]Walker V, Braum W, Menz G, Braum P, Schwarz F, Hansel T, Villiger B: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994, 150:1038-1048.
• [29]Moller D, Forman J, Liu M, Nobel P, Greenlee B, Vyas P, Holden D, Forrester J, Lazarus A, Wysocka M, Trinchieri G, Karp C: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996, 156:4952-4960.
• [30]Ota M, Amakawa R, Uehira K, Ito T, Yagi Y, Oshiro A, Date Y, Oyaizu H, Shigeki T, Ozaki Y, Yamaguchi K, Umeura Y, Yonezu S, Fukuhara S: Involvement of DCs in sarcoidosis. Thorax 2004, 59:408-413.
• [31]Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ: The anergic state in sarcoidosis is associated with diminishied dendritic cell function. J Immunol 2008, 181:746-755.
• [32]Lommatzsch M, Bratke K, Bier A, Julius P, Kuepper M, Luttmann W, Virchow JC: Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur Respir J 2007, 30:878-886.
• [33]Tateyama M, Fujihara K, Itoyama Y: Dendritic cells in muscle lesions of sarcoidosis. Hum Pathol 2011, 42:340-346.
• [34]Spears M, Mcsharry C, Donnelly I, Jolly L, Branningam M, Thomson J, Lafferty J, Chaundhuri R, Shepherd M, Cameron E, Thomson NC: Peripheral blood dendritic cell subtypes are significantly elevated in subjects with asthma. Clin Exp Allergy 2011, 41:665-672.
• [35]Upham JW, Denburg JA, O’Byrne PM: Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 2002, 32:818-823.
• [36]Bellini A, Vittori E, Marini M, Ackerman V, Mattoli S: Intraepithelial dendritic cells and selective activation of Th2-like lymphocytes in patients with atopic asthma. Chest 1993, 103:997-1005.
• [37]Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG: Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001, 56:823-826.
• [38]Möller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, Mulder PG, Postma DS, Hoogsteden HC: Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: down regulation by inhaled corticosteroids. Clin Exp Allergy 1996, 26:517-524.
• [39]Bratke K, Klug M, Bier A, Julius P, Kuepper M, Virchow C, Lammatzsch M: Function- associated surface molecules on airway dendritic cells in cigarette smokers. Am J Respir Cell Mol Biol 2008, 38:655-660.